Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThames Wat.u 35 Regulatory News (AW14)

Share Price Information for Thames Wat.u 35 (AW14)

Share Price is delayed by 15 minutes
Get Live Data
0.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: -
AW14 Live PriceLast checked at - London Stock Exchange

Intraday Thames Wat.u 35 Share Chart

PR24 Final Determination

19 Dec 2024 08:00

RNS Number : 7370Q
Thames Water Utilities Limited
19 December 2024
 

Thames Water Utilities Limited

19 December 2024

Thames Water receives its Final Determination for the regulatory period 2025 to 2030

Thames Water Utilities Limited (the "Company") has today received its Final Determination from its economic regulator, Ofwat, for the regulatory period running from 1 April 2025 to 31 March 2030.

The deliverability and investibility of Thames Water's Final Determination is critical to the Company's future and its ability to deliver improvements for customers and the environment.

Given its importance and complexity, Thames Water will take time to review the determination in detail before making its response. The Company will set out by early February the charges for customers that will apply from April 2025. These charges will reflect Ofwat's Final Determination, and Thames Water remains committed to supporting those customers who need help with their bills. 

Thames Water has previously announced a proposed transaction to extend its liquidity runway by up to £3.0 billion (the "Liquidity Extension Transaction"). The Board and leadership team remain focused on maintaining the stability of the business and increasing long-term financial resilience as well as on the delivery of its turnaround and the supply of essential services to 16 million customers across London, the Thames Valley and Home Counties.

Taking into account the proposed Liquidity Extension Transaction and the related STID Proposals, the Company's liquidity would be extended to October 2025, with the potential to extend further to May 2026 if the Company chooses to make an appeal to the CMA.

 

ENDS 

 

For further information

Investor enquiries

Frederick Maroudas - Director of Corporate Finance debt.investorrelations@thameswater.co.uk

Media enquiries

Suvra Jans - Head of Media Relations suvra.jans@thameswater.co.uk M: 07747 640 810

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFIFEDFILALIS
12
Date   Source Headline
27th Dec 20247:01 amRNSLiquidity Extension Update
27th Dec 20247:00 amRNSLiquidity Extension Update
20th Dec 20243:02 pmRNSTWUL - STID Proposal
19th Dec 20248:00 amRNSPR24 Final Determination
17th Dec 20246:13 pmRNSLiquidity Extension Update
17th Dec 20241:44 pmRNSLiquidity Extension Update
17th Dec 202410:00 amRNSLiquidity Extension Update
16th Dec 20244:57 pmRNSLiquidity Extension Update
13th Dec 20244:35 pmRNSLiquidity Extension Update
10th Dec 20247:19 amRNSInterim Financial Statements
10th Dec 20247:04 amRNSInterim Financial Statements
22nd Nov 202411:20 amRNSLiquidity Extension Update
18th Nov 20243:41 pmRNSSTID Proposal - Results Announcement
13th Nov 20247:00 amRNSLiquidity Extension Update
25th Oct 20243:14 pmRNSSTID Proposal - Notice of Bondholder Meetings
25th Oct 20243:12 pmRNSSTID Proposal Launch Announcement
25th Oct 20247:00 amRNSLiquidity Extension Update
30th Sep 202410:16 amRNSAnnual Financial Statements
20th Sep 20247:02 amRNSProcess Update
28th Aug 202412:28 pmRNSPR24 Draft Determination Response
31st Jul 20244:56 pmRNSS&P Ratings Action
24th Jul 202412:28 pmRNSMoody's ratings action
9th Jul 20247:00 amRNSAnnual Financial Report
9th Jul 20247:00 amRNSAnnual Financial Report
16th May 20247:00 amRNSDirector Change
22nd Apr 20247:00 amRNSPR24 Business Plan Update
28th Mar 20247:00 amRNSShareholder Funding Update
16th Feb 20248:00 amRNSCompany Information
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.